Published in Psychopharmacology (Berl) on June 27, 2006
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology (Berl) (2007) 1.64
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol (2008) 1.62
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol (2008) 1.34
The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Neuropsychopharmacology (2010) 1.28
Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis. Biol Mood Anxiety Disord (2013) 1.02
The potential role of dopamine D₃ receptor neurotransmission in cognition. Eur Neuropsychopharmacol (2013) 0.97
Pramipexole effects on startle gating in rats and normal men. Psychopharmacology (Berl) (2009) 0.93
Comparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers. Br J Clin Pharmacol (2007) 0.91
Prolactin and fMRI response to SKF38393 in the baboon. PeerJ (2013) 0.90
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects. Br J Clin Pharmacol (2008) 0.87
Reward processing abnormalities in Parkinson's disease. Mov Disord (2011) 0.84
Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation. Psychopharmacology (Berl) (2010) 0.82
Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers. Psychopharmacology (Berl) (2009) 0.81
Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis. Psychopharmacology (Berl) (2007) 0.79
Association between pupillometric sleepiness measures and sleep latency derived by MSLT in clinically sleepy patients. Environ Health Prev Med (2013) 0.78
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature (1990) 6.18
The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci (2001) 4.33
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. JAMA (2000) 4.10
The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci (2002) 3.13
Dopaminergic role in stimulant-induced wakefulness. J Neurosci (2001) 2.91
Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials. Am J Psychiatry (2002) 2.41
The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology (1971) 2.39
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther (2002) 1.87
Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord (2000) 1.78
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord (2003) 1.69
Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review. Psychopharmacologia (1976) 1.45
Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci (2002) 1.43
Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group. JAMA (1997) 1.43
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther (1997) 1.41
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord (2003) 1.34
Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res (2005) 1.23
Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology (2002) 1.18
The SHP test--an aid in the detection and measurement of depression. AMA Arch Gen Psychiatry (1959) 1.17
Mathematical procedures in data recording and processing of pupillary fatigue waves. Vision Res (1998) 1.16
The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers. Br J Psychiatry (1980) 1.14
Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Ther (1997) 1.13
Pupil size and spontaneous pupillary waves associated with alertness, drowsiness, and sleep. Neurology (1970) 1.13
Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology (2002) 1.07
Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease. Clin Neuropharmacol (1998) 1.04
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology (2002) 1.04
Parkinson's disease and RLS: the dopaminergic bridge. Sleep Med (2004) 1.02
Steady-state pharmacokinetic properties of pramipexole in healthy volunteers. J Clin Pharmacol (1997) 0.97
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group. Psychopharmacology (Berl) (1998) 0.96
Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats. Br J Pharmacol (1988) 0.95
Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. Psychopharmacology (Berl) (2005) 0.95
Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol (2003) 0.91
Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. J Psychopharmacol (2006) 0.90
A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol (2002) 0.90
The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav (2004) 0.90
Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? J Clin Psychopharmacol (2005) 0.89
Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers. Psychopharmacology (Berl) (2000) 0.88
Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol (2002) 0.88
Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.88
In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia. J Clin Psychopharmacol (2001) 0.87
Comparison of the effects of high ambient temperature and clonidine on autonomic functions in man. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.87
Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic. J Clin Psychopharmacol (1999) 0.86
Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease. CNS Drugs (2003) 0.83
Where you least expect it: dopamine in the pons and modulation of sleep and REM-sleep. Sleep (2003) 0.83
High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia. Int J Neuropsychopharmacol (2004) 0.83
Biochemical and radioautographic evidence for dopaminergic afferents of the locus coeruleus originating in the ventral tegmental area. J Neural Transm (1987) 0.82
The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers. J Psychopharmacol (2000) 0.80
The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers. Psychopharmacology (Berl) (1980) 0.80
Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons. J Pharmacol Exp Ther (1998) 0.79
Piribedil-induced sleep attacks in Parkinson's disease. Fundam Clin Pharmacol (2003) 0.79
Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers. Eur J Clin Pharmacol (1998) 0.79
Amisulpride: a review of its use in the management of schizophrenia. Drugs (2001) 0.79
Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil. J Sleep Res (1999) 0.78
Dopaminergic innervation of rat locus coeruleus: a light and electron microscopic immunohistochemical study. Microsc Res Tech (1994) 0.78
Hyperprolactinemia after low dose of amisulpride. Neuro Endocrinol Lett (2004) 0.78
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels. Neuropsychobiology (2002) 0.77
Relationship between sedation and pupillary function: comparison of diazepam and diphenhydramine. Br J Clin Pharmacol (2006) 0.76
Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects. Fundam Clin Pharmacol (1999) 0.75
The pathophysiology of cocaine abuse. J Clin Forensic Med (2003) 0.75
Behavior of humans in variable-interval schedules of reinforcement. J Exp Anal Behav (1976) 4.03
Effects of lesions of the orbitofrontal cortex on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology (Berl) (2002) 2.77
Effect of punishment on human variable-interval performance. J Exp Anal Behav (1977) 2.18
The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud (1992) 2.03
Mobility after stroke: reliability of measures of impairment and disability. Int Disabil Stud (1990) 1.94
The effect of signaled reinforcement availability on concurrent performances in humans. J Exp Anal Behav (1979) 1.91
Effect of variable-interval punishment on the behavior of humans in variable-interval schedules of monetary reinforcement. J Exp Anal Behav (1978) 1.90
Effect of tricyclic antidepressants on monoamine responses of single cortical neurones. Br J Pharmacol (1971) 1.86
Theory and method in the quantitative analysis of "impulsive choice" behaviour: implications for psychopharmacology. Psychopharmacology (Berl) (1999) 1.85
Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain (2008) 1.79
Effects of imipramine and desipramine on responses of single cortical neurones to noradrenaline and 5-hydroxytryptamine. Br J Pharmacol (1974) 1.78
The effect of punishment on free-operant choice behavior in humans. J Exp Anal Behav (1979) 1.78
The effect of microelectrophoretically applied mescaline on cortical neurones. Neuropharmacology (1974) 1.75
Relationship between response rate and reinforcement frequency in variable-interval schedules: the effect of the concentration of sucrose reinforcement. J Exp Anal Behav (1978) 1.72
Effects of quinolinic acid-induced lesions of the orbital prefrontal cortex on inter-temporal choice: a quantitative analysis. Psychopharmacology (Berl) (2002) 1.62
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol (2008) 1.62
Pharmacological responsiveness of sweat glands in anxious patients and healthy volunteers. Br J Psychiatry (1982) 1.56
Kinetics of the release of noradrenaline from micropipettes: interaction between ejecting and retaining currents. Br J Pharmacol (1973) 1.54
Attenuation of the pupillary light reflex in anxious patients. Br J Clin Pharmacol (1990) 1.52
Effects of iprindole on responses of single cortical and caudate neurones to monoamines and acetylcholine. Br J Pharmacol (1975) 1.51
The reflection of ejecting and retaining currents in the time-course of neuronal responses to microelectrophoretically applied drugs. J Pharm Pharmacol (1973) 1.40
Effect of mescaline on single cortical neurones. Br J Pharmacol (1971) 1.39
Clozapine-treated NMS. Br J Psychiatry (1991) 1.38
Effects of orbital prefrontal cortex dopamine depletion on inter-temporal choice: a quantitative analysis. Psychopharmacology (Berl) (2004) 1.37
Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology (Berl) (2000) 1.36
A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol (1977) 1.35
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol (2008) 1.34
The pharmacology of adrenergic neuronal responses in the cerebral cortex: evidence for excitatory alpha- and inhibitory beta-receptors. Br J Pharmacol (1977) 1.28
Effects of quinolinic acid-induced lesions of the nucleus accumbens core on inter-temporal choice: a quantitative analysis. Psychopharmacology (Berl) (2007) 1.27
The role of physical and biological factors in determining the time course of neuronal responses. Neuropharmacology (1974) 1.25
Effects of clonidine and yohimbine on the pupillary light reflex and carbachol-evoked sweating in healthy volunteers. Br J Clin Pharmacol (1991) 1.24
Human variable--interval performance. Psychol Rep (1976) 1.23
The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol (2000) 1.21
Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcers. Psychopharmacology (Berl) (1993) 1.16
Responses of single cortical neurones to noradrenaline and dopamine. Neuropharmacology (1978) 1.15
The effect of orbital prefrontal cortex lesions on performance on a progressive ratio schedule: implications for models of inter-temporal choice. Behav Brain Res (2005) 1.15
The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers. Br J Psychiatry (1980) 1.14
Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis. Psychopharmacology (Berl) (2000) 1.13
Relationship between response rate and reinforcement frequency in variable-interval schedules: II. Effect of the volume of sucrose reinforcement. J Exp Anal Behav (1981) 1.13
The effect of diazepam on the responsiveness of human eccrine sweat glands to carbachol: influence of ambient temperature. Eur J Clin Pharmacol (1987) 1.13
Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Psychopharmacology (Berl) (2000) 1.12
The effect of tricyclic antidepressants on cholinergic responses of single cortical neurones. Br J Pharmacol (1975) 1.12
Pupil responsiveness to tyramine in depressed patients treated with amitriptyline. Br J Clin Pharmacol (1975) 1.09
The inhibition of the pupillary light reflex by the threat of an electric shock: a potential laboratory model of human anxiety. J Psychopharmacol (1996) 1.08
Changes in autonomic function with age: a study of pupillary kinetics in healthy young and old people. Age Ageing (1996) 1.06
The fear-inhibited light reflex: importance of the anticipation of an aversive event. Int J Psychophysiol (2004) 1.05
Choice between delayed reinforcers in a discrete-trials schedule: the effect of deprivation level. Q J Exp Psychol B (1992) 1.04
Neuroleptic malignant syndrome. Br Med J (Clin Res Ed) (1984) 1.03
Proceedings: Potentiation and antagonism of neuronal responses to monoamines by methysergide and sotalol. Br J Pharmacol (1974) 1.03
Effect of central 5-hydroxytryptamine depletion on changeover behaviour in concurrent schedules of reinforcement. Psychopharmacology (Berl) (1999) 1.01
The effect of d-amphetamine on performance on two operant timing schedules. Psychopharmacology (Berl) (2000) 1.01
IgM antibodies in fish mucus. Proc Soc Exp Biol Med (1971) 1.01
Comparison of the effects of binodaline and amitriptyline on peripheral autonomic functions in healthy volunteers. Br J Clin Pharmacol (1985) 1.00
Role of the orbital prefrontal cortex in choice between delayed and uncertain reinforcers: a quantitative analysis. Behav Processes (2003) 1.00
Antagonism of phenylephrine-evoked sweating by trazodone and amitriptyline in humans in vivo. Br J Clin Pharmacol (1987) 0.99
5-hydroxytryptamine and impulse control: prospects for a behavioural analysis. J Psychopharmacol (1998) 0.99
Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man. J Psychopharmacol (1999) 0.99